No, the spreadsheet is the status of the applications as of a couple of days before the date that the spreadsheet is published. The 8 or so medicines added on 12/27/24 (including Blarcamesine) will either still be listed in clock stop (meaning they received an extension) or be back under review. That is my understanding.
Market Data 
Markets 
AI
